| Full of Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Reference and Education > Science > Human Evolution - Hardly a Closed Case |
|
Full of Articles - Human Evolution - Hardly a Closed Case
Polls have consistently shown that many Americans don't believe in evolution. In fact, According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product many Americans mistrust science in general. In the May/June 2007 issue of Archaeol ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ogy magazine, writer Zach Zorich describes the newly refurbished Hall of Human Ori lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. gins at the American Museum of Natural History. At the end of the review, Zorich relat here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe es his conversation with a security guard who works in the Hall. The guard tells Zoric d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro h he believes in evolution "sort of" but not "all the way." He wonders why, if the the ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ory of evolution is valid, do we still have monkeys? Zorich admits to feeling surprise easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi d by the guard's statement, but brushed it off as the inability of any one exhibit to nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically answer all questions. But gee, you'd think a guard who sees the evidence every day wo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ uld feel more than "sort of" convinced! In the January/February 2007 issue of Arch ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi aeology, two statistics are highlighted—first, 49% of Americans don't believe huma ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ns evolved over millions of years; second, 51% believe humans and dinosaurs coexisted. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod Even working in an evolution exhibit fails to convince. Why? Perhaps because reconstr cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin uctions of our presumed ancestors rely more on artistic license than facts. Complete s tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen keletons of hominids are rarer than fossils themselves. The famous Lucy, an example of t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Australopithecus, bequeathed to us only 40% of her skeleton. The skeletons gen ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust erally turn up in shattered bits spread out over a wide swathe of ground. Try this ev y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products olution experiment: take three jigsaw puzzles, dump them out of the boxes, remove 40% . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de of the pieces, scramble it all up, and—without looking at the pictures on the boxes—tr elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip y to reconstruct the puzzles. That's the state of human origins. ©2007 Lisa A. Shiel tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Fraud Prevention : Credit Card Do's and Don'ts Interested in Opening a Checking Account? What to Consider
|